Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based studyGemma Gatta, Alice Nennecke, Riccardo Capocaccia et al.|The Lancet Oncology|2017Cited by 510
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based studyGemma Gatta, Alice Nennecke, Laura Botta et al.|European Journal of Cancer|2015Cited by 486
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based studyRafael Cardoso, Marco Weber, Jan Mužı́k et al.|The Lancet Oncology|2021Cited by 477
Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 studyMilena Sant, Claire Schvartz, María Dolores Chirlaque López et al.|European Journal of Cancer|2015Cited by 279
Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized SettingMaarit K. Leinonen, Ahti Anttila, Pekka Nieminen et al.|JNCI Journal of the National Cancer Institute|2009Cited by 265